Cargando…
Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354437/ https://www.ncbi.nlm.nih.gov/pubmed/28301577 http://dx.doi.org/10.1371/journal.pone.0174493 |
_version_ | 1782515315107692544 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5354437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53544372017-04-06 Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer PLoS One Correction Public Library of Science 2017-03-16 /pmc/articles/PMC5354437/ /pubmed/28301577 http://dx.doi.org/10.1371/journal.pone.0174493 Text en © 2017 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer |
title | Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer |
title_full | Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer |
title_fullStr | Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer |
title_full_unstemmed | Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer |
title_short | Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer |
title_sort | correction: yes1 signaling mediates the resistance to trastuzumab/lap atinib in breast cancer |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354437/ https://www.ncbi.nlm.nih.gov/pubmed/28301577 http://dx.doi.org/10.1371/journal.pone.0174493 |
work_keys_str_mv | AT correctionyes1signalingmediatestheresistancetotrastuzumablapatinibinbreastcancer |